Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.

Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z.

Lancet. 2012 Apr 28;379(9826):1591-601. doi: 10.1016/S0140-6736(12)60209-8. Epub 2012 Mar 21.

PMID:
22440947
2.

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW.

Lancet. 2011 Jan 1;377(9759):31-41. doi: 10.1016/S0140-6736(10)62110-1. Epub 2010 Dec 6.

PMID:
21144578
3.

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.

Rothwell PM, Price JF, Fowkes FG, Zanchetti A, Roncaglioni MC, Tognoni G, Lee R, Belch JF, Wilson M, Mehta Z, Meade TW.

Lancet. 2012 Apr 28;379(9826):1602-12. doi: 10.1016/S0140-6736(11)61720-0. Epub 2012 Mar 21. Review.

PMID:
22440946
4.

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials.

Algra AM, Rothwell PM.

Lancet Oncol. 2012 May;13(5):518-27. doi: 10.1016/S1470-2045(12)70112-2. Epub 2012 Mar 21. Review.

PMID:
22440112
5.

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.

Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, Meade TW.

Lancet. 2010 Nov 20;376(9754):1741-50. doi: 10.1016/S0140-6736(10)61543-7. Epub 2010 Oct 21.

PMID:
20970847
6.

Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial.

Cook NR, Lee IM, Zhang SM, Moorthy MV, Buring JE.

Ann Intern Med. 2013 Jul 16;159(2):77-85. doi: 10.7326/0003-4819-159-2-201307160-00002.

7.

Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials.

Rothwell PM, Algra A, Chen Z, Diener HC, Norrving B, Mehta Z.

Lancet. 2016 Jul 23;388(10042):365-375. doi: 10.1016/S0140-6736(16)30468-8. Epub 2016 May 18.

8.

Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.

Flossmann E, Rothwell PM; British Doctors Aspirin Trial and the UK-TIA Aspirin Trial.

Lancet. 2007 May 12;369(9573):1603-13. Review.

PMID:
17499602
9.

Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.

De Schryver EL, Algra A, van Gijn J.

Cochrane Database Syst Rev. 2003;(1):CD001820. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD001820.

PMID:
12535415
10.

Aspirin Use in Adults: Cancer, All-Cause Mortality, and Harms: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Whitlock EP, Williams SB, Burda BU, Feightner A, Beil T.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Sep.

11.

Aspirin in gastrointestinal oncology: new data on an old friend.

Langley RE, Rothwell PM.

Curr Opin Oncol. 2014 Jul;26(4):441-7. doi: 10.1097/CCO.0000000000000098. Review.

PMID:
24840525
12.

Axillary treatment for operable primary breast cancer.

Bromham N, Schmidt-Hansen M, Astin M, Hasler E, Reed MW.

Cochrane Database Syst Rev. 2017 Jan 4;1:CD004561. doi: 10.1002/14651858.CD004561.pub3. Review.

PMID:
28052186
13.

Low-dose aspirin use and cancer characteristics: a population-based cohort study.

Jonsson F, Yin L, Lundholm C, Smedby KE, Czene K, Pawitan Y.

Br J Cancer. 2013 Oct 1;109(7):1921-5. doi: 10.1038/bjc.2013.411. Epub 2013 Jul 25.

14.

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Antithrombotic Trialists' Collaboration.

BMJ. 2002 Jan 12;324(7329):71-86. Erratum in: BMJ 2002 Jan 19;324(7330):141.

15.

Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.

Franklin J, Eichenauer DA, Becker I, Monsef I, Engert A.

Cochrane Database Syst Rev. 2017 Sep 13;9:CD008814. doi: 10.1002/14651858.CD008814.pub2. Review.

PMID:
28901021
16.

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.

Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE.

JAMA. 2005 Jul 6;294(1):47-55.

PMID:
15998890
17.

Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC).

Burn J, Mathers J, Bishop DT.

Recent Results Cancer Res. 2013;191:157-83. doi: 10.1007/978-3-642-30331-9_9. Review.

PMID:
22893205
18.

Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.

Tsao MN, Lloyd N, Wong RK, Chow E, Rakovitch E, Laperriere N, Xu W, Sahgal A.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD003869. doi: 10.1002/14651858.CD003869.pub3. Review. Update in: Cochrane Database Syst Rev. 2018 Jan 25;1:CD003869.

PMID:
22513917
19.

Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.

De Schryver EL, Algra A, van Gijn J.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD001820. Review. Update in: Cochrane Database Syst Rev. 2007;(3):CD001820.

PMID:
16625549
20.

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment.

Robertson L, Ghouri MA, Kovacs F.

Cochrane Database Syst Rev. 2012 Aug 15;(8):CD002071. doi: 10.1002/14651858.CD002071.pub3. Review.

PMID:
22895926

Supplemental Content

Support Center